Explore more topics
Stock report rankings

Highest-rated stocks similar to ONCO by NexusTrade rating

Compare companies related to Onconetix, Inc. Common Stock (ONCO), sorted by their latest eligible NexusTrade rating. Review each rating's fiscal period, model and date alongside dated fundamentals.

As of 2026-11-07T12:42:51.530Z

Eligible companies
94
Companies with usable ratings
94
Companies with dated fundamentals
93
List refreshed
2026-11-07
Underlying report dates
2025-12-31 to 2025-12-31
Market observation dates
2026-11-06 to 2026-11-06
Jump to a section

Ratings and dated fundamentals

Stored company report ratings

Scale: 0 to 4 / 5 · zero baseline

Stored company report ratings

  • IRMD+4 / 5
  • BSX+3.5 / 5
  • CNMD+3.5 / 5
  • ELMD+3.5 / 5
  • INMD+3.5 / 5
  • LMAT+3.5 / 5
  • MMSI+3.5 / 5
  • VCYT+3.5 / 5
  • INSP+3 / 5
  • UTMD+3 / 5

Exact eligible report scores in ranking order. Ratings summarize dated reports, not future returns; report and market dates remain in the table. Showing the first 10 of 93 recorded values; the complete table remains available below.

See the complete ratings and dated fundamentals

Scroll sideways to compare all columns. Select a heading to sort.

1iRadimed CorporationIRMD42025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$86.31$1,103,745,485.4346.0210.37
2Boston Scientific Corp.BSX3.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$42.75$61,964,980,240.517.73Not reported
3CONMED CorporationCNMD3.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$51.5$1,534,871,134.520.91.45
4Electromed, Inc.ELMD3.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$27.17$227,308,648.7120.114.21
5InMode Ltd. Ordinary SharesINMD3.52025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$13.33$767,063,812.768.171.12
6LeMaitre Vascular, Inc.LMAT3.52025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$80.89$1,850,833,655.1929.224.28
7Merit Medical Systems IncMMSI3.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$87.23$5,226,389,288.1232.643
8Veracyte, Inc.VCYT3.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$24.16$1,949,602,796.815.371.36
9Inspire Medical Systems, Inc.INSP32025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$63.98$1,853,252,293.6218.42.24
10Utah Medical Products IncUTMD32025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$72.23$229,967,174.1421.931.88
11Viemed Healthcare, Inc. Common SharesVMD32025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$9.13$345,963,948.2222.142.28
12Artivion, Inc.AORT2.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$20.21$986,041,292.12Not reported2.21
13AtriCure, Inc.ATRC2.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$58.54$2,980,990,446.82200.295.59
14Axogen, Inc. Common StockAXGN2.52025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$50.02$2,987,730,364.3Not reported6.02
15Baird Medical Investment Holdings Ltd Ordinary ShareBDMD2.52025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$0.09$2,825,894.72Not reported0.09
16Bioventus Inc. Class A Common StockBVS2.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$10.61$892,214,846.815.573.06
17Delcath Systems IncDCTH2.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$14.93$518,053,009.35973.784.28
18Embecta Corp. Common StockEMBC2.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$6.19$350,722,917.814.01Not reported
19NeoGenomics, Inc.NEO2.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$16.84$2,178,918,590.6Not reported2.72
20Anbio Biotechnology Class A Ordinary SharesNNNN2.52025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$3.89$170,736,76826.665.66
21Neuropace, Inc. Common StockNPCE2.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$12.5$429,053,425Not reported36.11
22Precipio, Inc. Common StockPRPO2.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$18.62$33,333,300.56Not reported2.26
23SI-BONE, Inc. Common StockSIBN2.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$24.24$1,093,541,228.88Not reported5.92
24SANUWAVE Health, Inc. Common StockSNWV2.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$2.19$18,839,056.711.326.76
25Sensus Healthcare, IncSRTS2.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$2.86$47,081,488.74Not reported1.28
26Staar Surgical CoSTAA2.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$25.21$1,265,587,856.992,387.93.36
27Xtant Medical Holdings, Inc.XTNT2.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$0.29$40,599,335.62Not reported1.01
28AETHLON MEDICAL INCAEMD22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$5.47$3,889,913.92Not reportedNot reported
29AngioDynamics, Inc.ANGO22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$11.73$493,298,698.5Not reported3.01
30Anika Therapeutics IncANIK22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$14.55$194,901,804.15Not reportedNot reported
31Accuray IncorporatedARAY22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$0.11$13,138,323.77Not reported0.32
32Cerus CorpCERS22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$2.02$407,947,451.68Not reported5.34
33CVRx, Inc. Common StockCVRX22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$0.87$24,744,936.01Not reported1.79
34Guardant Health, Inc. Common StockGH22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$150.87$20,410,595,048.25Not reportedNot reported
35GRAIL, Inc. Common StockGRAL22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$121.44$5,460,206,046.24Not reported2.23
36OrthoPediatrics Corp. Common StockKIDS22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$31.76$829,268,717.76Not reported2.44
37KORU Medical Systems, Inc. Common Stock (DE)KRMD22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$3.09$142,671,177.18Not reported7.9
38Pulmonx Corporation Common StockLUNG22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$2.56$111,489,702.4Not reported3.26
39Myomo Inc.MYO22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$1.21$47,925,503.34Not reported8.22
40InspireMD, Inc.NSPR22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$0.7$32,356,426.13Not reported1.03
41NovoCure Limited Ordinary SharesNVCR22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$13.28$1,552,643,935.52Not reported4.43
42OraSure Technologies IncOSUR22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$3.44$237,252,076.88Not reported0.75
43Pulse Biosciences, Inc Common Stock (DE)PLSE22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$53.29$3,919,422,159.96Not reported21.35
44Profound Medical Corp. Common StockPROF22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$7.21$264,079,545.24Not reported6.21
45Personalis, Inc. Common StockPSNL22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$15.79$1,711,696,223.06Not reported8.05
46RenovoRx, Inc. Common StockRNXT22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$1.13$54,523,168.96Not reported5.87
47Sight Sciences, Inc. Common StockSGHT22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$10.08$560,236,088.16Not reported11.4
48Sanara MedTech Inc. Common StockSMTI22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$31.55$289,882,504.25Not reported36.53
49Neuronetics, Inc. Common StockSTIM22025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$2.15$167,115,868.65Not reported7.46
50TELA Bio, Inc. Common StockTELA22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$0.82$36,813,700.74Not reportedNot reported
51Tempus AI, Inc. Class A Common StockTEM22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$76.05$13,338,483,040.35Not reported26.66
52Exagen Inc. Common StockXGN22025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$5.81$140,749,219.59Not reported11.52
53Autonomix Medical, Inc. Common StockAMIX1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$1.52$1,475,985.36Not reported0.47
54Bone Biologics Corp Common StockBBLG1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$0.33$1,129,911.6Not reported0.19
55Biodesix, Inc. Common StockBDSX1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$8.53$94,584,998.83Not reported10.9
56Bluejay Diagnostics, Inc. Common StockBJDX1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$2.35$1,165,414.35Not reported0.12
57BIOMERICA INCBMRA1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$1.61$7,404,338.48Not reported2.03
58Burning Rock Biotech Limited American Depositary SharesBNR1.52025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$13.42$874,860.54Not reported0.01
59Concord Medical Services Holding LimitedCCM1.52025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$3.71$16,107,791.71Not reported0.06
60ClearPoint Neuro, Inc. Common StockCLPT1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$8.6$275,666,704.8Not reported10.11
61Cytosorbents Corp.CTSO1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$4.8$15,082,257.6Not reportedNot reported
62Alpha Tau Medical Ltd. Ordinary SharesDRTS1.52025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$13.72$1,268,800,272.88Not reported16.46
63Elutia Inc. Class A Common StockELUT1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$0.84$37,087,801.20.722.36
64Establishment Labs Holdings Inc.ESTA1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$67.02$1,997,322,734.82Not reported92.44
65Femasys Inc. Common StockFEMY1.52025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$1.37$4,142,834.79Not reported1.03
66Vyome Holdings, Inc. Common StockHIND1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$1.58$11,089,274.24Not reported1.52
67IceCure Medical Ltd. Ordinary SharesICCM1.52025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$0.68$3,157,345.95Not reported0.35
68MDxHealth SA Ordinary SharesMDXH1.52025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$0.16$14,980,528.97Not reportedNot reported
69NeuroOne Medical Technologies Corporation Common StockNMTC1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$0.88$8,003,965.68Not reported2.12
70Neuraxis, Inc.NRXS1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$6.24$78,360,453.6Not reported11.63
71Nuwellis, Inc. Common StockNUWE1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$4.58$292,332.24Not reportedNot reported
72enVVeno Medical Corporation Common StockNVNO1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$6.73$4,676,178.98Not reported0.28
73Nexalin Technology, Inc. Common StockNXL1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$1.47$1,079,784.09Not reported0.71
74Orchestra BioMed Holdings, Inc. Ordinary SharesOBIO1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$5.68$341,396,678.32Not reported11.6
75Polyrizon Ltd. Ordinary SharesPLRZ1.52025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$11.05$26,823,931.18Not reportedNot reported
76Avita Medical, Inc. Common StockRCEL1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$16.59$518,730,571.45Not reportedNot reported
77Retractable Technologies, IncRVP1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$0.57$16,926,469.7Not reported0.23
78Senseonics Holdings, Inc. Common StockSENS1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$8.59$454,188,115.27Not reported5.03
79Sera Prognostics, Inc. Class A Common StockSERA1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$2.19$86,394,330.54Not reported1.65
80Streamex Corp. Common StockSTEX1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$0.34$39,481,776.36Not reported0.27
81TriSalus Life Sciences, Inc. Common StockTLSI1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$3.25$200,117,450Not reported30.55
82Treace Medical Concepts, Inc. Common StockTMCI1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$4.03$264,205,175.91Not reported4.29
83Tenon Medical, Inc. Common StockTNON1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$1.64$15,494.72Not reportedNot reported
84Virax Biolabs Group Limited Ordinary SharesVRAX1.52025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$0.79$1,065,096Not reported0.15
85WORK Medical Technology Group LTD Class A Ordinary SharesWOK1.52025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$0.95$4,223,648.24Not reported0.2
86Beyond Air, Inc. Common StockXAIR1.52025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$2.16$2,068,482.96Not reported0.73
87Adagio Medical Holdings, Inc Common StockADGM12025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$0.06$1,441,458.79Not reportedNot reported
88Advanced Biomed Inc. Common StockADVB12025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$1.98$3,271,223.340.490.27
89Anteris Technologies Global Corp. Common StockAVR12025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$5.69$554,538,717.06Not reported2.2
90Envoy Medical, Inc. Class A Common StockCOCH12025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$7.15$55,373,089.2Not reportedNot reported
91Cuprina Holdings (Cayman) Limited Class A Ordinary SharesCUPR12025-12-312025 FYopenrouter::anthropic/claude-haiku-5.52026-11-06$1.8$12,606,764.4Not reported3.21
92Solana Company Class A Common Stock (DE)HSDT12025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$1.93$116,685,296.79Not reported0.69
93ENDRA Life Sciences Inc. Common StockNDRA12025-12-312025 FYanthropic/claude-haiku-5-52026-11-06$4.73$7,094,233.74Not reported1.12

93 companies with eligible ratings and dated fundamentals, from 94 eligible companies in this selection.

Inspect a rated peer

Step 1 of 3

Ratings and dated fundamentals

Onconetix, Inc. Common Stock (ONCO): source evidence dated 2026-11-07T12:42:51.530Z.

Rank
1
Company
iRadimed Corporation
Ticker
IRMD
Rating / 5
4
Report date
2025-12-31
Fiscal period
2025 FY
Model
anthropic/claude-haiku-5-5
Market day
2026-11-06
What you should see

The selected ticker, rating, report date and producing model match the first displayed row. Equal ratings use ticker order.

Step 2 of 3

Which recorded peer has the highest usable rating?

The provider's peer set defines membership. It does not establish identical risk or business models. Read report dates and producing models.

NexusTrade stock ratings and report filters
Median market capitalization
$142,671,177.18 · 93 / 93 displayed companies
Median positive P/E (TTM)
20.51 · 20 / 93 displayed companies
Median positive price / book
2.44 · 79 / 93 displayed companies
Largest company by market cap
Boston Scientific Corp. (BSX) · $61,964,980,240.5
Largest company's share of displayed market cap
41.86% · Sum of displayed market caps; not portfolio weights or revenue exposure
What you should see

Check each median’s included count and each company’s market date. These are unweighted summaries of displayed companies, not a sector index or revenue exposure.

Step 3 of 3

Research ONCO

Open a peer's company view and compare how it actually earns revenue with the anchor company.

Research ONCO
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

How these companies are related

Peer membership comes from the same related-company provider used by NexusTrade's stock research. The provider identifies related companies using news coverage and returns data. A related company can be a competitor or a thematic peer; this list does not imply identical products or financial exposure.

Peer membership was fetched 2026-10-12.

The rating determines the order after peer membership is selected. The anchor company is excluded. Companies without an eligible report rating or dated fundamentals are counted in coverage and left out of the ranked table.

What best means in this list

This list was refreshed on 2026-11-07 using existing company reports. The report date in each row is the date of the underlying analysis; refreshing the list does not create a new company report.

Best means the highest stored NexusTrade report ratings within this selection. Ratings use the product's 1-to-5 scale. The list sorts by rating from high to low, with ticker order breaking equal-rating ties. A rating summarizes a report; it does not predict a stock's return.

The peer set comes from the recorded related-company provider. Similarity defines which companies enter this comparison; it does not establish that they have equal business models, risk or expected returns.

What the leading companies do

The first 5 companies below lead the ratings in this snapshot; equal ratings are ordered by ticker. Their company profiles describe different businesses even when they share the Onconetix, Inc. Common Stock (ONCO) selection.

These are company descriptions, not estimates of revenue from this theme. Industry membership does not identify a pure-play business or establish how much sales depend on it. Open the company profile and examine segment disclosures before treating an overlapping classification as equivalent exposure.

  1. iRadimed Corporation (IRMD): 4 / 5

    IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida.

  2. Boston Scientific Corp. (BSX): 3.5 / 5

    Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

  3. CONMED Corporation (CNMD): 3.5 / 5

    CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

  4. Electromed, Inc. (ELMD): 3.5 / 5

    Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

  5. InMode Ltd. Ordinary Shares (INMD): 3.5 / 5

    InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.

Valuation and company size within this selection

These summaries use the 93 displayed companies. Each company retains its own market observation date in the ratings table above. Medians are unweighted; they are not a sector index valuation.

Positive P/E and price-to-book values are summarized separately. Missing, zero and negative values are excluded from those medians, with the included count shown. A lower multiple alone does not establish better value: profitability, growth, debt and business mix can differ.

Show the table · 5 rows, 3 columns

Scroll sideways to compare all columns. Select a heading to sort.

Median market capitalization$142,671,177.1893 / 93 displayed companies
Median positive P/E (TTM)20.5120 / 93 displayed companies
Median positive price / book2.4479 / 93 displayed companies
Largest company by market capBoston Scientific Corp. (BSX)$61,964,980,240.5
Largest company's share of displayed market cap41.86%Sum of displayed market caps; not portfolio weights or revenue exposure

Other business classifications in the list

A company can appear in several product and revenue classifications. These overlapping memberships help identify different business mixes to investigate; they are not verified revenue shares or mutually exclusive subindustries.

Show the table · 5 rows, 2 columns
Additional classificationMatching displayed companies
Healthcare93 / 93
Medical Devices91 / 93
Technology60 / 93
Hardware51 / 93
Manufacturing51 / 93

Dates and coverage

Report dates range from 2025-12-31 to 2025-12-31. Market observations range from 2026-11-06 to 2026-11-06. These dates may differ across companies. Daily closes are not synchronized live quotes.

The selection includes 0 companies without a report, 0 with invalid latest rating metadata, 0 with older reports, 1 with missing required fundamentals and 0 with out-of-date market observations. Missing companies receive no substitute score.

How the ranking is built

The ranking uses the latest stored report at or before the refresh cutoff for each active eligible company. The report date, fiscal year/period and producing model remain visible. The latest invalid score is excluded; an older favorable score does not replace it. Publication policy stock-ratings-v1 accepts report ages up to 550 days and market observations up to 10 calendar days, with a positive close and market capitalization. Optional missing ratios remain not reported.

Report ages can differ substantially, particularly between annual and quarterly reports. Different producing models may also use different judgments. Read the date, fiscal period and model before comparing scores. Private report analysis and account data are not published here.

A refresh reads existing reports and market data. It does not rerun a model or create a new analysis. Compare business fundamentals and your own research constraints alongside the score before making a decision.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.